BTIG Reinstates Buy on Orthofix Medical, Announces $27 Price Target
Portfolio Pulse from richadhand@benzinga.com
BTIG analyst Ryan Zimmerman has reinstated a 'Buy' rating on Orthofix Medical (NASDAQ:OFIX) and announced a price target of $27.
July 19, 2023 | 10:26 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Orthofix Medical has been reinstated with a 'Buy' rating by BTIG analyst Ryan Zimmerman, with a price target of $27.
The reinstatement of the 'Buy' rating and the setting of a price target by a BTIG analyst indicates a positive outlook for the company. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100